NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Virongy Biosciences

Virongy Biosciences

Private
Manassas, VirginiaHealthcare & Life Scienceshttps://virongy.com/

Last Round

Corporate Funding

May 17, 2022

Total Funding Raised

$471,000

Company Overview

Virongy Biosciences is a biotechnology company that provides research platforms, viral diagnostic tools, and laboratory services for virology and gene therapy research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

viral vector platformpseudoviruscontract research organizationCROantiviral drug screeningneutralization assaybiotech reagentsgene therapy developmentviral transductionstable cell lineBSL-2 researchwet-lab servicesbiodefense researchcustom peptide synthesis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Virongy Biosciences Comparables

Compare Virongy Biosciences with similar companies based on industry and business-model similarity.

Virongy Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BPS Bioscience
78%
CellBio Scientific
72%
Sartorius Aktiengesellschaft
66%

Virongy Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMay 17, 2022

Key People

Founding team and executive leadership

Brian Hetrick

Chief Executive Officer

Executive Team

Virongy Biosciences Investors

Notable investors and investment history

Virongy Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Virongy Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Virongy Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersManassas, Virginia
Employee Range5
Year Founded2013
Last FundingMay 17, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.